Clinical Trial Update: Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly Diagnosed [Phase 2]

View source ↗

Summary

The document reports a Phase 2 clinical trial of Lendexal in newly diagnosed primary systemic amyloidosis (AL). The study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Amyloidosis

Drugs mentioned

• Lendexal

Snippet

Sponsor: PETHEMA Foundation | Conditions: Primary Systemic Amyloidosis | Phase 2 | Status: COMPLETED